Cedars-Sinai Technology Ventures oversees more than 1,100 patents
The team manages a portfolio of more than 500 technologies in various stages of development and has generated more than $1 billion in technology transfer revenue over the past five years.
As the name implies, Cedars-Sinai Technology Ventures (CSTV) is the commercialization arm of the prominent academic medical center in Los Angeles.
Led by James D. Laur, JD, Chief Intellectual Property Officer, the CSTV team manages a portfolio of more than 500 technologies in various stages of development, oversees more than 1,100 patents, and has generated more than $1 billion in technology transfer revenue over the past five years.
The Technology Ventures enterprise also includes the Cedars-Sinai Accelerator, which engages with early stage health-tech start-ups. There is also a complementary Health Ventures fund where Cedars-Sinai invests in new technologies and early stage companies whose research and technologies hold the potential to transform the delivery of healthcare in more efficient and cost-effective ways.
Click here to learn more about the work of CSTV.
Like what you've read?
Forward to a friend!